Walgreens Boots Alliance Management

Management Kriterienprüfungen 1/4

Walgreens Boots Alliance's CEO ist Tim Wentworth , ernannt in Oct 2023, hat eine Amtszeit von weniger als ein Jahr. besitzt direkt 0.068% der Aktien des Unternehmens, im Wert von $8.86M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 0.9 Jahre bzw. 3.7 Jahre.

Wichtige Informationen

Tim Wentworth

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	less than a year
Eigentum des Geschäftsführers	0.07%
Durchschnittliche Amtszeit des Managements	less than a year
Durchschnittliche Amtszeit der Vorstandsmitglieder	3.8yrs

Jüngste Management Updates

Recent updates

Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Apr 08

Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed

Apr 04

Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem

Mar 27

Walgreens' Strategic Pivot

Mar 21

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Mar 15

Walgreens: New CEO Looking To Right The Ship

Feb 13

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Jan 19

Walgreens Boots Alliance: Income Opportunity After Dividend Cut

Jan 17

Walgreens Q1: Dividend Cut Now What? (Rating Upgrade)

Jan 10

After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar

Dec 24

Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48

Oct 31

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Oct 02

Walgreens Boots Alliance (NASDAQ:WBA) Will Pay A Dividend Of $0.48

Aug 01

Walgreens Boots Alliance (NASDAQ:WBA) Has Announced A Dividend Of $0.48

Jul 16

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Jul 04

Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48

Apr 25

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Mar 08

Walgreens Boots Alliance (NASDAQ:WBA) Has Affirmed Its Dividend Of $0.48

Feb 01

Geschäftsführer

Tim Wentworth (64 yo)

less than a year

Amtszeit

Mr. Timothy C. Wentworth, also known as Tim, served as Director of Ushur, Inc. since February 2022. He served as the Chief Executive Officer of Evernorth at Evernorth Health, Inc. (formerly known as Expres...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Stefano Pessina	Executive Chairman of the Board	12.3yrs	US$7.57m	0.076% $ 7.2m
Manmohan Mahajan	Executive VP & Global CFO	less than a year	US$1.83m	0.019% $ 1.9m
Ornella Barra	Chief Operating Officer of International	no data	US$5.43m	0.24% $ 22.6m
Timothy Wentworth	CEO & Director	less than a year	keine Daten	0.068% $ 6.5m
Todd Heckman	Senior VP	less than a year	keine Daten	0.0010% $ 95.8k
Neal Sample	Executive VP & Chief Information Officer	less than a year	keine Daten	keine Daten
Tiffany Kanaga	Vice President of Global Investor Relations	no data	keine Daten	keine Daten
Matthew D'Ambrosio	Senior VP and Global Chief Compliance & Ethics Officer	no data	keine Daten	keine Daten
Lanesha Minnix	Executive VP & Global Chief Legal Officer	less than a year	keine Daten	keine Daten
Elizabeth Burger	Executive VP & Chief Human Resources Officer	no data	keine Daten	keine Daten
Liyue Wu	Head of M&A - Asia	no data	keine Daten	keine Daten
Tracey Brown	Executive VP	2.7yrs	keine Daten	0.0030% $ 288.4k

1.0yrs

Durchschnittliche Betriebszugehörigkeit

53.5yo

Durchschnittliches Alter

Erfahrenes Management: WBADas Führungsteam des Unternehmens gilt nicht als erfahren ( 0.9 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Stefano Pessina	Executive Chairman of the Board	12.3yrs	US$7.57m	0.076% $ 7.2m
Timothy Wentworth	CEO & Director	less than a year	keine Daten	0.068% $ 6.5m
Ginger Graham	Lead Independent Director	14.3yrs	US$366.85k	0.00025% $ 24.0k
Valerie Jarrett	Independent Director	3.8yrs	US$300.00k	0.00052% $ 49.8k
Nancy Schlichting	Independent Director	17.8yrs	US$319.97k	0% $ 0
John Lederer	Independent Director	9.3yrs	US$315.00k	0.0058% $ 554.8k
Bryan Hanson	Independent Director	1.8yrs	US$84.62k	0.0011% $ 107.3k
Janice Babiak	Independent Director	12.3yrs	US$325.00k	0.00014% $ 13.4k
Inderpal Bhandari	Independent Director	1.8yrs	US$115.29k	0.00035% $ 33.5k
Thomas Polen	Director	less than a year	US$14.13k	0.00020% $ 19.2k
Robert Huffines	Independent Director	less than a year	keine Daten	keine Daten

3.8yrs

Durchschnittliche Betriebszugehörigkeit

66yo

Durchschnittliches Alter

Erfahrener Vorstand: WBADie Vorstandsmitglieder gelten als erfahren (3.7 Jahre durchschnittliche Amtszeit).

Walgreens Boots Alliance Management

Management Kriterienprüfungen 1/4

Wichtige Informationen

Jüngste Management Updates

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Walgreens Boots Alliance, Inc. Announces Executive Changes

High number of new directors

Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 25, 2024

Walgreens Boots Alliance Names Neal Sample Executive Vice President and Chief Information Officer

Recent updates

Walgreens: Yielding Over 8% Following The Earnings Drop

Boots Chief Quits Reportedly After Walgreens' Sale Plan Stalls

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target decreased by 9.0% to US$20.21

Consensus EPS estimates fall by 41%

Walgreens: Beware The Value Trap Ahead Of Earnings

Walgreens Boots Alliance, Inc. to Report Q3, 2024 Results on Jun 27, 2024

Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)

5 Reasons Walgreens Fell By 6.4% To Nearly 25-Year Lows

Walgreens Announces Launch of Walgreens Brand Naloxone HCI Nasal Spray

Walgreens Reportedly Contacts Potential Buyers for £7 Billion Boots Drugstore Chain

Upcoming dividend of US$0.25 per share

Walgreens: Hold Tight, Let It Turn Around First

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Second quarter dividend of US$0.25 announced

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on June 12, 2024

3 Reasons Walgreens Can See Upside (Rating Upgrade)

Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed

New major risk - Financial position

Consensus EPS estimates fall by 11%

Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem

Walgreens' Strategic Pivot

Consensus EPS estimates increase by 11%

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Consensus EPS estimates fall by 14%

Walgreens: New CEO Looking To Right The Ship

Walgreens Boots Alliance, Inc. Announces Executive Changes

Upcoming dividend of US$0.25 per share at 4.4% yield

High number of new directors

Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors

Walgreens Reportedly Explores $4 Billion-Plus Sale of Shields Health

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Walgreens Boots Alliance: Income Opportunity After Dividend Cut

Walgreens Q1: Dividend Cut Now What? (Rating Upgrade)

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on March 12, 2024

After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar

The Shareholder Commons, Inc Files a Notice of Exempt Solicitation to Walgreens Boots Alliance, Inc

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 25, 2024

Walgreens Boots Alliance, Inc. to Report Q1, 2024 Results on Jan 04, 2024

Upcoming dividend of US$0.48 per share at 8.7% yield

Walgreens Boots Alliance Names Neal Sample Executive Vice President and Chief Information Officer

Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on December 12, 2023

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Full year 2023 earnings: EPS misses analyst expectations

Price target decreased by 10.0% to US$27.77

Walgreens Boots Alliance, Inc. Appoints Tim Wentworth as Chief Executive Officer, Effective October 23, 2023

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Walgreens Boots Alliance, Inc.(NasdaqGS:WBA) dropped from S&P 100

Dicello Levitt Files Lawsuit Against Kenvue, Procter & Gamble, Glaxosmithkline, and Walgreens

Walgreens Boots Alliance, Inc. Announces CEO Changes

Upcoming dividend of US$0.48 per share at 6.6% yield

High number of new directors

Walgreens Boots Alliance (NASDAQ:WBA) Will Pay A Dividend Of $0.48

Walgreens Boots Alliance, Inc. Announces Departure of James Kehoe as Executive Vice President

Walgreens Boots Alliance (NASDAQ:WBA) Has Announced A Dividend Of $0.48

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on September 12, 2023

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into an agreement to acquire 120 pharmacies in Texas, Louisiana and Arkansas from Brookshire Grocery Company.

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Price target decreased by 9.5% to US$36.27

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

An unknown buyer acquired 6.004471% stake in Option Care Health, Inc. (NasdaqGS:OPCH) from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for approximately $330 million.

Walgreens Boots Alliance, Inc. to Report Q3, 2023 Results on Jun 27, 2023

Upcoming dividend of US$0.48 per share at 6.1% yield